SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-216909
Filing Date
2019-08-08
Accepted
2019-08-08 16:38:41
Documents
6
Effectiveness Date
2019-08-08

Document Format Files

Seq Description Document Type Size
1 S-8 d764410ds8.htm S-8 88248
2 EX-5.1 d764410dex51.htm EX-5.1 8214
3 EX-10.5 d764410dex105.htm EX-10.5 36763
4 EX-10.6 d764410dex106.htm EX-10.6 36731
5 EX-23.1 d764410dex231.htm EX-23.1 2024
6 GRAPHIC g764410g0808210255939.jpg GRAPHIC 2196
  Complete submission text file 0001193125-19-216909.txt   176373
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-233137 | Film No.: 191010127
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10